Literature DB >> 33539018

Bile Acid Toxicity and Protein Kinases.

Atilla Engin1.   

Abstract

If the bile acids reach to pathological concentrations due to cholestasis, accumulation of hydrophobic bile acids within the hepatocyte may result in cell death. Thus, hydrophobic bile acids induce apoptosis in hepatocytes, while hydrophilic bile acids increase intracellular adenosine 3',5'-monophosphate (cAMP) levels and activate mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) pathways to protect hepatocytes from apoptosis.Two apoptotic pathways have been described in bile acids-induced death. Both are controlled by multiple protein kinase signaling pathways. In mitochondria-controlled pathway, caspase-8 is activated with death domain-independent manner, whereas, Fas-dependent classical pathway involves ligand-independent oligomerization of Fas.Hydrophobic bile acids dose-dependently upregulate the inflammatory response by further stimulating production of inflammatory cytokines. Death receptor-mediated apoptosis is regulated at the cell surface by the receptor expression, at the death-inducing signaling complex (DISC) by expression of procaspase-8, the death receptors Fas-associated death domain (FADD), and cellular FADD-like interleukin 1-beta (IL-1β)-converting enzyme (FLICE) inhibitory protein (cFLIP). Bile acids prevent cFLIP recruitment to the DISC and thereby enhance initiator caspase activation and lead to cholestatic apoptosis. At mitochondria, the expression of B-cell leukemia/lymphoma-2 (Bcl-2) family proteins contribute to apoptosis by regulating mitochondrial cytochrome c release via Bcl-2, Bcl-2 homology 3 (BH3) interacting domain death agonist (Bid), or Bcl-2 associated protein x (Bax). Fas receptor CD95 activation by hydrophobic bile acids is initiated by reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent reactive oxygen species (ROS) signaling. However, activation of necroptosis by ligands of death receptors requires the kinase activity of receptor interacting protein1 (RIP1), which mediates the activation of RIP3 and mixed lineage kinase domain-like protein (MLKL). In this chapter, mainly the effect of protein kinases signal transduction on the mechanisms of hydrophobic bile acids-induced inflammation, apoptosis, necroptosis and necrosis are discussed.

Entities:  

Keywords:  Apical sodium bile acid cotransporter (ASBT); Bile acid; Canalicular bile salt export pump (BSEP); Cholangiocytes; Glycochenodeoxycholic acid (GCDCA); Hydrophobic bile acids; Na+/taurocholate (TC) cotransporter (NTCP); Tauroursodeoxycholic acid (TUDCA); Transmembrane G-protein-coupled receptor (TGR5); Ursodeoxycholic acid (UDCA)

Year:  2021        PMID: 33539018     DOI: 10.1007/978-3-030-49844-3_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  192 in total

1.  Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.

Authors:  Gianfranco Alpini; Leonardo Baiocchi; Shannon Glaser; Yoshiyuki Ueno; Marco Marzioni; Heather Francis; Jo Lynne Phinizy; Mario Angelico; Gene Lesage
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

2.  Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.

Authors:  Katryn Allen; Hartmut Jaeschke; Bryan L Copple
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 3.  Bile acid transporters: structure, function, regulation and pathophysiological implications.

Authors:  Waddah A Alrefai; Ravinder K Gill
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

4.  Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes.

Authors:  G Alpini; S S Glaser; R Rodgers; J L Phinizy; W E Robertson; J Lasater; A Caligiuri; Z Tretjak; G D LeSage
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

5.  Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes.

Authors:  G Alpini; Y Ueno; S S Glaser; M Marzioni; J L Phinizy; H Francis; G Lesage
Journal:  Hepatology       Date:  2001-11       Impact factor: 17.425

6.  Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling.

Authors:  Katryn Allen; Nam Deuk Kim; Jeon-Ok Moon; Bryan L Copple
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-17       Impact factor: 4.219

7.  Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways.

Authors:  Gianfranco Alpini; Noriatsu Kanno; Jo Lynne Phinizy; Shannon Glaser; Heather Francis; Silvia Taffetani; Gene LeSage
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-12-30       Impact factor: 4.052

8.  Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats.

Authors:  Gianfranco Alpini; Shannon Glaser; Domenico Alvaro; Yoshiyuki Ueno; Marco Marzioni; Heather Francis; Leonardo Baiocchi; Tonino Stati; Barbara Barbaro; Jo Lynne Phinizy; Jeremy Mauldin; Gene Lesage
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

Review 9.  LKB1-dependent signaling pathways.

Authors:  Dario R Alessi; Kei Sakamoto; Jose R Bayascas
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

10.  Activation of necroptosis in human and experimental cholestasis.

Authors:  Marta B Afonso; Pedro M Rodrigues; André L Simão; Dimitry Ofengeim; Tânia Carvalho; Joana D Amaral; Maria M Gaspar; Helena Cortez-Pinto; Rui E Castro; Junying Yuan; Cecília M P Rodrigues
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

View more
  1 in total

Review 1.  Role and Regulation of Hepatobiliary ATP-Binding Cassette Transporters during Chemical-Induced Liver Injury.

Authors:  Carolina I Ghanem; Jose E Manautou
Journal:  Drug Metab Dispos       Date:  2022-08-01       Impact factor: 3.579

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.